Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Turmeric and Reduced Nuclear Factor Kappa B p65 Level

Doses used in studies

mg/day: 1,200 (median 1,200, IQR 1,200–1,200) — 1 study

Time to effect

Median: 3 months · IQR 3 months–3 months · Range 3 months–3 months — Reported in 1 of 1 study

1 of 1 paper

Curcuma longa improves endothelial glycocalyx integrity and redox-inflammatory pathways in type 2 diabetes mellitus: a randomized double-blind placebo-controlled study.
- 2026-04
- RCT
- European journal of nutrition 65(3)
- - Drielly Rodrigues Viudes
  - Alanna Ramalho Mateus
  - Cristina Antoniali Silva
  - Maria do Carmo Franco
- PubMed: 41984245
- DOI: 10.1007/s00394-026-03963-3
14 Insights on
- Reduced Nuclear Factor Kappa B p65 Level
- High evidence
- Rigorous Journal
- Clinical
CLE reduced NF-κB p65 levels (P < 0.001)
Effect
Beneficial
Effect size
Small
Significant
Yes
Dose
1200 mg/day